91 related articles for article (PubMed ID: 17671693)
21. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
22. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
23. Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance.
Schoenlein PV; Periyasamy-Thandavan S; Samaddar JS; Jackson WH; Barrett JT
Autophagy; 2009 Apr; 5(3):400-3. PubMed ID: 19221464
[TBL] [Abstract][Full Text] [Related]
24. Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.
Roberts CG; Millar EK; O'Toole SA; McNeil CM; Lehrbach GM; Pinese M; Tobelmann P; McCloy RA; Musgrove EA; Sutherland RL; Butt AJ
Oncogene; 2011 Jul; 30(28):3186-97. PubMed ID: 21383694
[TBL] [Abstract][Full Text] [Related]
25. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
26. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells.
Cesarone G; Garofalo C; Abrams MT; Igoucheva O; Alexeev V; Yoon K; Surmacz E; Wickstrom E
J Cell Biochem; 2006 May; 98(2):440-50. PubMed ID: 16440325
[TBL] [Abstract][Full Text] [Related]
27. Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro.
Zeisig R; Teppke AD; Behrens D; Fichtner I
Breast Cancer Res Treat; 2004 Oct; 87(3):245-54. PubMed ID: 15528967
[TBL] [Abstract][Full Text] [Related]
28. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture.
El Etreby MF; Liang Y; Lewis RW
Prostate; 2000 Apr; 43(1):31-42. PubMed ID: 10725863
[TBL] [Abstract][Full Text] [Related]
30. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
Devulapally R; Sekar TV; Paulmurugan R
Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
[TBL] [Abstract][Full Text] [Related]
31. A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen.
Lehn S; Fernö M; Jirström K; Rydén L; Landberg G
Cell Cycle; 2011 Mar; 10(6):956-62. PubMed ID: 21358261
[TBL] [Abstract][Full Text] [Related]
32. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice.
El Etreby MF; Liang Y
Breast Cancer Res Treat; 1998 May; 49(2):109-17. PubMed ID: 9696393
[TBL] [Abstract][Full Text] [Related]
33. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance.
Samaddar JS; Gaddy VT; Duplantier J; Thandavan SP; Shah M; Smith MJ; Browning D; Rawson J; Smith SB; Barrett JT; Schoenlein PV
Mol Cancer Ther; 2008 Sep; 7(9):2977-87. PubMed ID: 18790778
[TBL] [Abstract][Full Text] [Related]
34. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
[TBL] [Abstract][Full Text] [Related]
35. Bis(ethyl)norspermine potentiates the apoptotic activity of the pure antiestrogen ICI 182780 in breast cancer cells.
Balabhadrapathruni S; Santhakumaran LM; Thomas TJ; Shirahata A; Gallo MA; Thomas T
Oncol Rep; 2005 Jan; 13(1):101-8. PubMed ID: 15583809
[TBL] [Abstract][Full Text] [Related]
36. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells.
Chisholm K; Bray BJ; Rosengren RJ
Anticancer Drugs; 2004 Oct; 15(9):889-97. PubMed ID: 15457130
[TBL] [Abstract][Full Text] [Related]
38. The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.
Bosco EE; Wang Y; Xu H; Zilfou JT; Knudsen KE; Aronow BJ; Lowe SW; Knudsen ES
J Clin Invest; 2007 Jan; 117(1):218-28. PubMed ID: 17160137
[TBL] [Abstract][Full Text] [Related]
39. Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines.
Marth C; Mayer I; Daxenbichler G
Biochem Pharmacol; 1984 Jul; 33(14):2217-21. PubMed ID: 6087819
[TBL] [Abstract][Full Text] [Related]
40. RB pathway and therapeutic sensitivity: new insights in breast cancer and Tamoxifen therapy.
Witkiewicz AK; Knudsen ES
Cell Cycle; 2011 May; 10(10):1525. PubMed ID: 21502809
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
